Kato T, Wang Z W, Zoega T, Crowe R R
Department of Psychiatry, University of Iowa College of Medicine, Iowa City 52242-1000, USA.
Am J Med Genet. 1996 Jul 26;67(4):401-5. doi: 10.1002/(SICI)1096-8628(19960726)67:4<401::AID-AJMG14>3.0.CO;2-N.
Cholecystokinin tetrapeptide (CCK4) is known to induce panic attacks in patients with panic disorder at a lower dose than in normal controls. Therefore, the cholecystokinin B (CCKB) receptor gene is a candidate gene for panic disorder. We searched for mutations in the CCKB gene in 22 probands of panic disorder pedigrees, using single-strand conformation polymorphism (SSCP) analysis. Two polymorphisms were detected. A polymorphism in an intron (2491 C-->A) between exons 4 and 5 was observed in 10 of 22 probands. A missense mutation in the extracellular loop of exon 2 (1550 G-->A, Val125-->Ile) was found in only one proband. This mutation was also examined in additional 34 unrelated patients with panic disorder and 112 controls. The prevalence rate of this mutation was 8.8% in patients with panic disorder (3/34) and 4.4% in controls (5/112). The mutation did not segregate with panic disorder in two families where this could be tested. These results suggest no pathophysiological significance of this mutation in panic disorder.
已知胆囊收缩素四肽(CCK4)在惊恐障碍患者中诱发惊恐发作的剂量低于正常对照者。因此,胆囊收缩素B(CCKB)受体基因是惊恐障碍的一个候选基因。我们使用单链构象多态性(SSCP)分析,在22个惊恐障碍家系的先证者中搜索CCKB基因的突变。检测到两个多态性。在22个先证者中的10个中观察到外显子4和5之间的一个内含子中的多态性(2491 C→A)。仅在1个先证者中发现外显子2细胞外环中的一个错义突变(1550 G→A,Val125→Ile)。在另外34名无亲缘关系的惊恐障碍患者和112名对照者中也检测了该突变。该突变在惊恐障碍患者中的患病率为8.8%(3/34),在对照者中为4.4%(5/112)。在两个可以进行检测的家系中,该突变与惊恐障碍没有连锁关系。这些结果表明该突变在惊恐障碍中没有病理生理学意义。